Use of a NAT-based assay to improve the surveillance system and prevent transfusion-transmitted malaria in blood banks

Table 3 Cycle threshold (Ct) values for LPM–IOC samples tested individually with the NAT Plus System

Patient	Source	Gender	Microscopy/real-time PCR	NAT plus (Ct value)
1	LPM–IOC	M	P. vivax	29.86
2	LPM–IOC	M	P. vivax	30.76
3	LPM–IOC	F	P. vivax	32.34
4	LPM–IOC	M	P. vivax	32.42
5	LPM–IOC	M	P. vivax	29.71
6	LPM–IOC	M	P. vivax	31.4
7	LPM–IOC	F	P. vivax	30.07
8	LPM–IOC	M	P. vivax	32.61
9	LPM–IOC	M	P. vivax	31.76
10	LPM–IOC	M	P. vivax	31.35
11	LPM–IOC	M	P. vivax	33.42
12	LPM–IOC	M	P. vivax	28.23
13	LPM–IOC	M	P. vivax	32.78
14	LPM–IOC	M	P. vivax	33.6
15	LPM–IOC	M	P. vivax	31.3
16	LPM–IOC	M	P. vivax	26.42
17	LPM–IOC	F	P. vivax	26.62
18	LPM–IOC	M	P. vivax	32.5
19	LPM–IOC	M	P. vivax	29.5
20	LPM–IOC	F	P. vivax	30.84
21	LPM–IOC	F	P. vivax	26.32
22	LPM–IOC	F	P. vivax	29.35
23	LPM–IOC	M	P. vivax	32.17
24	LPM–IOC	M	P. vivax	30.82
25	LPM–IOC	M	P. vivax	35.9
26	LPM–IOC	M	P. vivax	30.83
27	LPM–IOC	M	P. vivax	31.27
28	LPM–IOC	M	P. vivax	27.78
29	LPM–IOC	M	P. vivax	31.48
30	LPM–IOC	M	P. vivax	32.85
31	LPM–IOC	M	P. vivax	29.73

ISSN: 1475-2875